City

Minneapolis (1)

Condition

NAFLD (1)

Non-Alcoholic Fatty Liver Disease (1)

Pediatric NAFLD (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University of Minnesota (1)

Collaborator

Intervention

empagliflozin 10 mg (1)

placebo oral tablet (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

pediatric nafld

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non-Alcoholic Fatty Liver Disease, NAFLD, Pediatric NAFLD Trial in Minneapolis (Empagliflozin 10 MG, Placebo Oral Tablet)

Active, not recruiting

Non-Alcoholic Fatty Liver Disease
+2 more

Empagliflozin 10 MG
Placebo Oral Tablet

Minneapolis, Minnesota

University of Minnesota

Mar 2, 2022